Depondt, Chantal
Van Paesschen, Wim http://orcid.org/0000-0002-8535-1699
van Rijckevorsel, Kenou
Leunikava, Iryna
Ferrière, France http://orcid.org/0000-0003-4371-9253
Funding for this research was provided by:
UCB Pharma
Article History
Accepted: 30 March 2021
First Online: 31 May 2021
Declarations
:
: The Medical Need Program as well as this retrospective data collection and related publications were sponsored by UCB Pharma.
: CD received grants paid to the institution from UCB Pharma during the conduct of the study as well as grants, speaker’s fees, and conference support from UCB Pharma outside the submitted work. WVP received nonfinancial support from UCB Pharma during the conduct of the study as well as personal fees and nonfinancial support from UCB Pharma, grants from EIT Health, and personal fees from Idorsia outside the submitted work. KvR has no relevant relationships to disclose. IL and FF are employees of UCB Pharma.
: The Ethics Committees of all participating centers were approached for their consent of the MNP and to inform them of the data collection. Anonymized data entry was conducted by site personnel or data entry assistants upon request of the treating physicians and approval by Ethics Committees.
: In the context of this real-life data collection, no informed consent was required due to the retrospective design and the nature of the information collected. The sponsor only had access to fully anonymized data.
: The datasets generated and/or analyzed during the current study are not publicly available as data from non-interventional studies is outside of UCB’s data sharing policy.
: Not applicable.
: FF and IL were responsible for the study conception. CD, WVP, and KvR contributed to the study conception, were participating investigators in the data collection, and members of the Medical Need Program. All authors were responsible for data interpretation. Medical writing assistance (funded by UCB Pharma) was provided under the direction of the authors. All authors reviewed and commented on previous versions of the manuscript. All authors read and approved the final manuscript and agreed to the submission to <i>Drugs-Real World Outcomes</i>.